GLP-1 Prescriptions for Weight Loss by Differences in Insurance Plan Coverage

This cross-sectional study reports trends in glucagon-like peptide-1 (GLP-1) prescriptions for plans that do and do not cover GLP-1s for weight loss.

Corresponding Author: Mahnum Shahzad, PhD, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 401 Park Dr, Ste 401, Boston, MA 02215 (mahnum_shahzad@g.harvard.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.